GSK plc
GSK · NYSE, OTC · CIK 0001131399
SIC 2834
Pharmaceutical Preparations
Category
Chemicals
Entity
other
Incorp.
X0
Fiscal Y/E
-
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$49.83
-0.58 (-1.15%)
Open
$50.65
High
$50.92
Low
$49.71
Prev Close
$50.41
Volume
3,335,560
Quote as of: 2026-05-11
Financial Statements
No XBRL data — applies to ETFs and some funds📄 SEC Filings
Foreign Current
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN
2026-05-11
Open →
Foreign Current
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME
2026-05-11
Open →
Foreign Current
RESULT OF AGM
2026-05-06
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-05-05
Open →
Foreign Current
TOTAL VOTING RIGHTS
2026-05-01
Open →
Foreign Current
HOLDING(S) IN COMPANY
2026-05-01
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-29
Open →
Foreign Current
1ST QUARTER RESULTS
2026-04-29
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-28
Open →
Foreign Current
BEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCE
2026-04-28
Open →
Foreign Current
EFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONS
2026-04-27
Open →
Foreign Current
TESARO UPDATE ON ANAPTYSBIO INC. LITIGATION
2026-04-27
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-24
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-23
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-22
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-21
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-20
Open →
Foreign Current
BLENREP APPROVED IN CHINA FOR 2L+ MULTIPLE MYELOMA
2026-04-20
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-20
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-17
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-16
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-16
Open →
Foreign Current
GSK COMPLETES ACQUISITION OF 35PHARMA INC.
2026-04-15
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-15
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-14
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-14
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-13
Open →
Foreign Current
GSK PRESENTS POSITIVE DATA FOR BEHOLD 1 B7 H4 ADC
2026-04-13
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-13
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-10
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-10
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-09
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-09
Open →
Foreign Current
EXDENSUR APPROVED FOR CRSWNP IN CHINA
2026-04-08
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-08
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-07
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-02
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-04-01
Open →
Foreign Current
TOTAL VOTING RIGHTS
2026-04-01
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-04-01
Open →
Foreign Current
VIIV COMPLETES CHANGES TO MINORITY SHAREHOLDING
2026-04-01
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-31
Open →
Foreign Current
BEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINA
2026-03-30
Open →
Foreign Current
EXDENSUR APPROVED FOR SEVERE ASTHMA IN CHINA
2026-03-30
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-30
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-27
Open →
Foreign Current
BEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMA
2026-03-27
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-26
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-25
Open →
Foreign Current
NOTICE OF AGM
2026-03-25
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-25
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-24
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-23
Open →
Foreign Current
ADMISSION TO TRADING
2026-03-23
Open →
Foreign Current
GSK LUNG CANCER ADC GETS JAPAN ORPHAN DRUG STATUS
2026-03-23
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-23
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-20
Open →
Foreign Current
LYNAVOY (LINERIXIBAT) APPROVED BY US FDA
2026-03-19
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-19
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-18
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-18
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-17
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-17
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-16
Open →
Foreign Current
US FDA APPROVES AREXVY FOR ADULTS 18-49 AIR
2026-03-13
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-13
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-12
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-12
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-11
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-10
Open →
Foreign Current
BOARD COMMITTEE CHANGE
2026-03-09
Open →
Foreign Current
GSK AND ALFASIGMA AGREE GLOBAL LINERIXIBAT RIGHTS
2026-03-09
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-09
Open →
Foreign Current
FILING OF GSK PLC 2025 ANNUAL REPORT ON FORM 20-F
2026-03-06
Open →
Foreign Annual
20-F
2026-03-06
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-06
Open →
Foreign Current
GSK PUBLISHES ANNUAL REPORT 2025
2026-03-05
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-05
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-03-04
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-04
Open →
Foreign Current
GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS
2026-03-03
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-03
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-03-02
Open →
Foreign Current
TOTAL VOTING RIGHTS
2026-03-02
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-02-27
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-02-27
Open →
Foreign Current
LINERIXIBAT ACCEPTED FOR PRIORITY REVIEW IN CHINA
2026-02-26
Open →
Foreign Current
BEPIROVIRSEN ACCEPTED FOR JAPAN REGULATORY REVIEW
2026-02-26
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-02-26
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-02-25
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-02-25
Open →
Foreign Current
GSK ENTERS AGREEMENT TO ACQUIRE 35PHARMA
2026-02-25
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-02-25
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2026-02-24
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-02-24
Open →
Foreign Current
TRANSACTION IN OWN SHARES
2026-02-23
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2022-02-11
Open →
Foreign Current
DIRECTOR/PDMR SHAREHOLDING
2022-02-11
Open →
Foreign Current
BENLYSTA APPROVED IN CHINA FOR LUPUS NEPHRITIS
2022-02-10
Open →
Foreign Annual
20-F
2021-03-12
Open →
Foreign Annual
20-F
2020-03-06
Open →
Foreign Annual
20-F
2019-03-15
Open →
Other filings (8)
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-05-06
Open →
IRANNOTICE
IRANNOTICE
2026-03-06
Open →
SC TO-T/A
SC TO-T/A
2026-03-03
Open →
SC TO-T/A
SC TO-T/A
2026-02-24
Open →
6-K/A
DIRECTOR/PDMR SHAREHOLDING - AMENDMENT
2021-08-13
Open →
6-K/A
GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATES
2020-02-03
Open →
6-K/A
DIRECTOR/PDMR SHAREHOLDING
2018-05-09
Open →
20-F/A
20-F/A
2018-03-20
Open →